Emflaza

Deflazacort

Emflaza is a corticosteroid indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients at the age of 5 and older.
more
Pakkaus Per pilleri Hinta Säästöt Tilaus
180 tablet
€ 0.67
€ 119.85€ 0.67
€ 211.90
120 tablet
€ 0.77
€ 92.18€ 0.77
€ 128.98
90 tablet
€ 0.92
€ 82.96€ 0.92
€ 82.91
60 tablet
€ 1.15
€ 69.13€ 1.15
€ 41.46
30 tablet
€ 1.84
€ 55.29€ 1.84
Pakkaus Per pilleri Hinta Säästöt Tilaus
120 tablet
Ilmainen toimitus lentorahtina Hot
€ 4.23
€ 507.22€ 4.23
€ 92.05
90 tablet
Ilmainen toimitus lentorahtina Hot
€ 4.46
€ 401.15€ 4.46
€ 48.29
60 tablet
Ilmainen toimitus lentorahtina Hot
€ 4.61
€ 276.64€ 4.61
€ 22.99
36 tablet
Ilmainen toimitus lentorahtina Hot
€ 4.87
€ 175.19€ 4.87
€ 4.59
24 tablet
€ 4.99
€ 119.85€ 4.99
Pakkaus Per pilleri Hinta Säästöt Tilaus
90 tablet
Ilmainen toimitus lentorahtina Hot
€ 5.12
€ 461.10€ 5.12
€ 92.10
60 tablet
Ilmainen toimitus lentorahtina Hot
€ 5.53
€ 331.98€ 5.53
€ 36.82
36 tablet
Ilmainen toimitus lentorahtina Hot
€ 5.89
€ 212.08€ 5.89
€ 9.20
24 tablet
Ilmainen toimitus lentorahtina Hot
€ 6.15
€ 147.52€ 6.15
Emflaza

Tuotemerkki(kit)

Valmistaja

  • Lupin

Sairaudet

  • Duchenne Muscular Dystrophy / DMD

Deflazacort tablets

What is this medicine?

Deflazacort a corticosteroid indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients 5 years of age and older.

What should I tell my health care providers before I take this medicine?

They need to know if you have any of these conditions:

  • Hypersensitivity to deflazacort;
  • Alterations in Endocrine Function: Hypothalamic-pituitary-adrenal axis suppression, Cushing’s syndrome, and hyperglycemia;
  • Immunosuppression and Increased Risk of Infection: Increased risk of new, exacerbation, dissemination, or reactivation of latent infections, which can be severe and at times fatal;
  • Alterations in Cardiovascular/Renal Function: elevated blood pressure and sodium, and for decreased potassium level;
  • Gastrointestinal Perforation: GI disorders;
  • Behavioral and Mood Disturbances: euphoria, insomnia, mood swings, personality changes, severe depression, and psychosis;
  • Effects on Bones: decreases in bone mineral density;
  • Serious Skin Rashes;
  • Ophthalmic Effects: May include cataracts, infections, and glaucoma;
  • Vaccination: Do not administer live or live attenuated vaccines to patients receiving immunosuppressive doses of corticosteroids.

How should I use this medicine?

The recommended once-daily dosage is approximately 0.9 mg/kg/day administered orally. Discontinue gradually when administered for more than a few day..

What may interact with this medicine?

  • Moderate or strong CYP3A4 inhibitors: Give one third of the recommended dosage;
  • Avoid use of moderate or strong CYP3A4 inducers, as they may reduce efficacy.

What side effects may I notice from this medicine?

The most common adverse reactions are Cushingoid appearance, weight increased, increased appetite, upper respiratory tract infection, cough, pollakiuria, hirsutism, central obesity, and nasopharyngitis.